ConductScience.org, home

Paper14745321

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.

Cillo U and 10 others. Ann Surg, 2004. Cited by 269 papers, by iCite.

Cite this record

ConductScience Library. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Papers, record 14745321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14745321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.
PubMed
Journal
Ann Surg
PubMed
Year
2004
PubMed
Publication types
Comment, Journal Article
PubMed
Citations, by iCite
269
iCite
Relative citation ratio, by iCite
7.38
iCite
Revised in PubMed
2022-03-21
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cillo UUmberto
2Vitale AAlessandro
3Bassanello MMarco
4Boccagni PPatrizia
5Brolese AAlberto
6Zanus GGiacomo
7Burra PPatrizia
8Fagiuoli SStefano
9Farinati FFabio
10Rugge MMassimo
11D'Amico DFDavide Francesco

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Liver TransplantationMajor topic
Adult
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Survival Rate

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in15492579Liver transplantation for hepatocellular carcinoma: need for a new patient selection strategy.https://conductscience.org/library/papers/15492579PubMed
Comment on14745322Challenging choices: liver transplantation for hepatocellular carcinoma.https://conductscience.org/library/papers/14745322PubMed

Download CSV of comments and corrections

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110573522Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.Hepatology1999https://conductscience.org/library/papers/10573522PubMed
310458250Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.J Clin Oncol1999https://conductscience.org/library/papers/10458250PubMed
410385644Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.Hepatology1999https://conductscience.org/library/papers/10385644PubMed
59790338Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.Ann Surg1998https://conductscience.org/library/papers/9790338PubMed
69742501Surgical options for hepatocellular carcinoma: resection and transplantation.Liver Transpl Surg1998https://conductscience.org/library/papers/9742501PubMed
79620329Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power.Hepatology1998https://conductscience.org/library/papers/9620329PubMed
89409568Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.Ann Surg1997https://conductscience.org/library/papers/9409568PubMed
99252157The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.Hepatology1997https://conductscience.org/library/papers/9252157PubMed
108619179Clinical features of small hepatocellular carcinomas as assessed by histologic grades.Surgery1996https://conductscience.org/library/papers/8619179PubMed
118594428Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996https://conductscience.org/library/papers/8594428PubMed
128393649Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients.Ann Surg1993https://conductscience.org/library/papers/8393649PubMed
132171452Is liver transplantation justified for the treatment of hepatic malignancies?Arch Surg1990https://conductscience.org/library/papers/2171452PubMed
1410636104Implications of human macrophage metalloelastase and vascular endothelial growth factor gene expression in angiogenesis of hepatocellular carcinoma.Ann Surg2000https://conductscience.org/library/papers/10636104PubMed
1510649244Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?Cancer2000https://conductscience.org/library/papers/10649244PubMed
1610861421Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival.Cancer2000https://conductscience.org/library/papers/10861421PubMed
1711030244Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.J Am Coll Surg2000https://conductscience.org/library/papers/11030244PubMed
1811106101Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.J Gastroenterol Hepatol2000https://conductscience.org/library/papers/11106101PubMed
1911124835
RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.
Hepatology2001https://conductscience.org/library/papers/11124835PubMed
2011146770Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.Arch Surg2001https://conductscience.org/library/papers/11146770PubMed
2111176129Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study.Ann Surg2001https://conductscience.org/library/papers/11176129PubMed

See all 43 referencesDownload CSV of references

Cited by87

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 269 citations.

PMIDTitleJournalYearIn PapersSource
42281878Multifaceted role of histopathology in liver transplantation for hepatocellular carcinoma: A narrative review towards precision prognosis.World J Transplant2026https://conductscience.org/library/papers/42281878PubMed
39125552Differentiating Well-Differentiated from Poorly-Differentiated HCC: The Potential and the Limitation of Gd-EOB-DTPA in the Presence of Liver Cirrhosis.Diagnostics (Basel)2024https://conductscience.org/library/papers/39125552PubMed
38946462
Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on "Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging".
Clin Mol Hepatol2024https://conductscience.org/library/papers/38946462PubMed
38541138Evolution of Liver Transplantation Indications: Expanding Horizons.Medicina (Kaunas)2024https://conductscience.org/library/papers/38541138PubMed
38067299Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues.Cancers (Basel)2023https://conductscience.org/library/papers/38067299PubMed
35619164Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?Eur J Med Res2022https://conductscience.org/library/papers/35619164PubMed
35468711Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review.Clin Mol Hepatol2022https://conductscience.org/library/papers/35468711PubMed
34837039Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade.Sci Rep2021https://conductscience.org/library/papers/34837039PubMed
34786178Clinical outcomes of patients with two small hepatocellular carcinomas.World J Hepatol2021https://conductscience.org/library/papers/34786178PubMed
34638365Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation.Cancers (Basel)2021https://conductscience.org/library/papers/34638365PubMed
34513597Liver transplantation in malignant disease.World J Clin Oncol2021https://conductscience.org/library/papers/34513597PubMed
34501381Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review.J Clin Med2021https://conductscience.org/library/papers/34501381PubMed
34159158Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?Hepatobiliary Surg Nutr2021https://conductscience.org/library/papers/34159158PubMed
34003479Hepatocellular cancer selection systems and liver transplantation: from the tower of babel to an ideal comprehensive score.Updates Surg2021https://conductscience.org/library/papers/34003479PubMed
32490334Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience.Ann Gastroenterol Surg2020https://conductscience.org/library/papers/32490334PubMed
32039389Recent advances in liver transplantation for cancer: The future of transplant oncology.JHEP Rep2019https://conductscience.org/library/papers/32039389PubMed
32039350Controversies in the management of hepatocellular carcinoma.JHEP Rep2019https://conductscience.org/library/papers/32039350PubMed
31938228Improved performance of Hangzhou criteria for liver transplantation of hepatocellular carcinoma: the role of liver resident FoxP3+ regulatory T cells.Int J Clin Exp Pathol2018https://conductscience.org/library/papers/31938228PubMed
31015392Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant.Ann Transplant2019https://conductscience.org/library/papers/31015392PubMed
30705718Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation.World J Hepatol2019https://conductscience.org/library/papers/30705718PubMed

See all 87 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TENM110178PubTator's text mininghttps://conductscience.org/library/genes/10178

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14745321

GET https://conductscience.org/api/papers/v1/14745321/references?page=2